Subthalamic Nucleus Stimulation With Directional Leads on Patients With Parkinson Disease at Fluctuations and Dyskinesia Stage
- Conditions
- Directional ElectrodesParkinson DiseaseSubthalamic Nucleus Stimulation
- Registration Number
- NCT05103072
- Lead Sponsor
- Centre Hospitalier Universitaire, Amiens
- Brief Summary
Patients with subthalamic nucleus have to go through a lot of examinations and tests, before and after surgery which is difficult, sometimes painful, for the patient.
The investigators used to chose the best plot of the leads for stimulation by a procedure long and exhausting for the patient and the examinator.
The investigators can chose the plot using a software (Guide Xt), which can delete the exhausting test.
The investigators would like to study the non inferiority of this tool to choose the best plot .
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 13
- age : >18Y
- All patient with Parkinson disease eligible for sub thalamic surgery (CAPSIT criterias) in CHU AMIENS
- patient doesn't consent
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Increase of MDS UPDRS 3 score 3 months The MDS-UPDRS was developed to evaluate various aspects of Parkinson's disease including non-motor and motor experiences of daily living and motor complications.
The MDS-UPDRS has four parts, namely, I: Non-motor Experiences of Daily Living; II: Motor Experiences of DailyLiving; III: Motor Examination; IV: Motor Complications.Twenty questions are completed by the patient/caregiver. Item-specific instructions and an appendix of complementary additional scales are provided.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
CHU Amiens Picardie
🇫🇷Amiens, Picardie, France